MIRM FY2025 EPS Forecast Raised by Cantor Fitzgerald
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) – Investment analysts at Cantor Fitzgerald raised their FY2025 earnings per share estimates for shares of Mirum Pharmaceuticals in a research report issued to clients and investors on Thursday, February 27th. Cantor Fitzgerald analyst J. Schimmer now forecasts that the company will post earnings per share of ($1.40) […]
